Headline
The latest stories from AHA Today.
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of artificial intelligence-enabled medical devices.
The Centers for Medicare & Medicaid Services Innovation Center will launch a new, outcome-aligned payment model for providers offering technology-supported care to individuals with Original Medicare for managing common chronic conditions. The Advancing Chronic Care with Effective, Scalable…
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration to include IRFs in Texas and California.
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through internal testing. The devices are being permanently recalled and the FDA advised customers to stop using the product.
Eilidh Pederson, CEO at Western Wisconsin Health, shares lessons from her unique birthing experience — in which she delivered her own baby — and outlines how rural hospitals can continue to provide needed access to safe, high-quality maternity health services in rural America. LISTEN NOW
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations under the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT announced Nov. 24 that it will exercise temporary enforcement discretion for health IT developers regarding certification criteria compliance dates and attestations of condition and maintenance for…
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027.
The Trump administration issued an executive order (https://www.whitehouse.gov/presidential-actions/2025/11/launching-the-genesis-mission/) Nov. 24 launching the Genesis Mission, an artificial intelligence initiative focusing on scientific research.
The Food and Drug Administration has identified a Class I recall of Max Mobility/Permobil SpeedControl Dials used with the SmartDrive MX2+ Power Assist Device for wheelchairs after identifying a design issue that can lead to unexpected behavior of the SmartDrive motor.